EP1957378A1 - Blister pack with fold lines - Google Patents
Blister pack with fold linesInfo
- Publication number
- EP1957378A1 EP1957378A1 EP06824308A EP06824308A EP1957378A1 EP 1957378 A1 EP1957378 A1 EP 1957378A1 EP 06824308 A EP06824308 A EP 06824308A EP 06824308 A EP06824308 A EP 06824308A EP 1957378 A1 EP1957378 A1 EP 1957378A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- blister pack
- weakness
- accommodation
- connecting part
- lines
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D83/00—Containers or packages with special means for dispensing contents
- B65D83/04—Containers or packages with special means for dispensing contents for dispensing annular, disc-shaped, or spherical or like small articles, e.g. tablets or pills
- B65D83/0445—Containers or packages with special means for dispensing contents for dispensing annular, disc-shaped, or spherical or like small articles, e.g. tablets or pills all the articles being stored in individual compartments
- B65D83/0463—Containers or packages with special means for dispensing contents for dispensing annular, disc-shaped, or spherical or like small articles, e.g. tablets or pills all the articles being stored in individual compartments formed in a band or a blisterweb, inserted in a dispensing device or container
- B65D83/0472—Containers or packages with special means for dispensing contents for dispensing annular, disc-shaped, or spherical or like small articles, e.g. tablets or pills all the articles being stored in individual compartments formed in a band or a blisterweb, inserted in a dispensing device or container the band being wound in flat spiral, folded in accordion or the like
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D75/00—Packages comprising articles or materials partially or wholly enclosed in strips, sheets, blanks, tubes, or webs of flexible sheet material, e.g. in folded wrappers
- B65D75/28—Articles or materials wholly enclosed in composite wrappers, i.e. wrappers formed by associating or interconnecting two or more sheets or blanks
- B65D75/30—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding
- B65D75/32—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents
- B65D75/325—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents one sheet being recessed, and the other being a flat not- rigid sheet, e.g. puncturable or peelable foil
- B65D75/327—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents one sheet being recessed, and the other being a flat not- rigid sheet, e.g. puncturable or peelable foil and forming several compartments
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D75/00—Packages comprising articles or materials partially or wholly enclosed in strips, sheets, blanks, tubes, or webs of flexible sheet material, e.g. in folded wrappers
- B65D75/52—Details
- B65D75/527—Tear-lines for separating a package into individual packages
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D2585/00—Containers, packaging elements or packages specially adapted for particular articles or materials
- B65D2585/56—Containers, packaging elements or packages specially adapted for particular articles or materials for medicinal tablets or pills
Definitions
- the invention relates to a blister pack for dosage forms of a pharmaceutical formulation which is suitable for enteral administration, such as tablets, pills or capsules, comprising a plurality of accommodation units which are interconnected along lines of weakness, each accommodation unit being provided with a piercable base sheet and a cap part which is fixed to the base sheet, an accommodation space for accommodating an object being formed between the base sheet and the cap part of each accommodation unit.
- Such a blister pack is known.
- the blister pack forms a primary pack.
- the packed dosage forms such as tablets, pills, capsules and the like, are also indicated below by the term objects. These objects are situated between the cap part and the base sheet.
- the cap part can be deformed by heat, so that individual accommodation units are produced. Each accommodation unit is sufficiently large to contain the form of the individual object.
- the cap part is closed off by the base sheet, which is fixed to the cap part.
- This type of blister pack is sold in a container, such as a cardboard box, which surrounds the blister pack.
- the container forms a secondary pack.
- a disadvantage of this pack is, however, that because of the design of Hie blister pack described above, optimum use cannot be made of the available volume of the container, Le. the secondary pack. The latter contains a considerable empty space. Furthermore, the base sheet does not provide sufficient security, with the result that the contents can come out of it prematurely. This means that it is possible for the objects to come out of the pack accidentally.
- the individual accommodation units are torn off the standard blister pack, sharp edges occur on the pack, so that the user can injure himself and/or can damage the environment, and in particular the base sheet of the pack.
- the small mutual distance between the individual accommodation units makes them difficult to tear off. The result is that a number of adjacent base sheets of the individual accommodation units can be opened accidentally. Furthermore, the individual redistribution of the individual accommodation units, such as commonly occurs in institutions, is time-consuming and inefficient.
- an object of the invention it to provide a blister pack which at least partially overcomes one or more of the abovementioned drawbacks.
- This object is achieved according to the invention in that the blister pack comprises a plurality of connecting parts, each of which is connected by way of two respective lines of weakness to at least one accommodation unit in each case.
- the blister pack according to the invention can be folded up along its lines of weakness.
- the connecting parts which are provided between the accommodation units in such a way that they can be folded along the lines of weakness
- the accommodation units can be placed, for example, alternately back to back against each other. This means that the space between the individual accommodation units is reduced, in other words the accommodation units of the folded blister pack according to the invention are packed more closely against each other. Since the volume taken up in the blister pack is then reduced, this produces a saving of space.
- the empty space in the secondary pack which surrounds the blister pack according to the invention can be reduced.
- the secondary pack can consequently contain a blister pack with more objects, or the secondary pack can be made smaller while accommodating a blister pack with the same number of objects.
- the blister pack can, for example, contain ten pills or more, hi this case the connecting parts and the accommodation units connected to them can be aligned with each other in order to form an elongated, possibly folded strip.
- Said strip therefore comprises a series of accommodation units and connecting parts, which are connected to each other by way of the lines of weakness.
- the blister pack according to the invention it is also possible for the blister pack according to the invention to comprise a plurality of such series or strips which are interconnected parallel to and adjacent to each other along lines of weakness.
- a further advantage of the blister pack according to the invention is that it means that less secondary packaging material is needed.
- the primary packaging material is also reduced by reducing the contact surface between the individual accommodation units by using connecting parts, with the result that it is possible to provide the individual accommodation units with a maximum material-saving method, which is possibly based on the contents of the individual accommodation units.
- the blister pack according to the invention prevents damage to the pack itself, injury to the user and damage to the environment of the pack, owing to the fact that the accommodation unit does not have any sharp comers.
- Another advantage is that user convenience is increased by the fact of simply tearing along the lines of weakness of the individual accommodation units, since the mutual distance between the individual accommodation units is increased in pairs by the mutual connecting parts. This gives users more space to press the individual contents per accommodation unit out of the primary pack through base sheet, which reduces the risk of accidentally pressing out several accommodation units.
- Another advantage is more efficient redistribution of the individual accommodation units by the fact that the connecting parts make it possible to wind the primary packaging material onto a core body, so mat large quantities of individual accommodation units can be supplied on a roll.
- a pharmaceutical pack is disclosed in US3659706.
- This pack has a pair of blister sheets which are interconnected by a hinge part
- the blister sheets can be folded along the hinge part, so that the blister sheets lie above one another.
- the cap parts of the blister sheets are accommodated inside each other after folding.
- This pack is not, however, provided with a plurality of connecting parts, so that the accommodation units of the blister sheets cannot be individually folded.
- the base sheet of this blister pack faces outwards, which increases the risk of damage.
- a pack is disclosed in GB 2096574.
- This pack comprises a transparent cover which is fixed to a cardboard base sheet A bottle is accommodated between the two.
- a plurality of these packs can be connected to each other by way of perforation lines.
- a spacer is provided between two pairs of interconnected packs. This makes it possible to fold up the packs.
- this pack does not relate to dosage forms of a pharmaceutical formulation which is suitable for enteral administration.
- the lines of weakness of the connecting part to be situated on either side of said connecting part. In this case the lines of weakness are provided on opposite edges of the connecting part. The lines of weakness extend substantially parallel to each other.
- the connecting part or each connecting part prefferably be connected by way of each line of weakness thereof to a pair of accommodation units which are directly connected to each other by way of a line of weakness.
- two accommodation units in each case are directly connected to each other along a line of weakness, which two accommodation units form a pair.
- a connecting part is provided in each case between said pairs of accommodation units, which connecting part is connected by way of lines of weakness to each pair.
- each accommodation unit prefferably be of a height which is determined by the distance running substantially perpendicularly relative to the base sheet from the base sheet to the top of the cap part, and for the connecting part to be of a length which is determined by the distance between its lines of weakness, and for the length of the connecting part to be substantially greater than or equal to the height of an accommodation unit
- the lines of weakness of a connecting part are the lines of weakness by means of which said connecting part is connected to one or two accommodation units in each case.
- the length of the connecting part is at least equal to substantially twice the height of an accommodation unit. If the ratio of said length and said height is substantially equal to two, the blister pack can be folded up in zigzag fashion to a particularly compact size.
- the length of the connecting parts can, however, also be greater than twice the height of the accommodation units.
- each accommodation unit prefferably be of a length which is determined by the distance between the lines of weakness by means of which said accommodation unit is connected to a connecting part and/or further accommodation unit, and for the length of the connecting part to be substantially less than the length of the accommodation unit.
- the lines of weakness of an accommodation unit are the lines of weakness by means of which said accommodation unit is connected to a connecting part or a further accommodation unit in each case.
- each accommodation unit and each connecting part is of a respective width which in each case is determined by its maximum distance in the direction running substantially parallel to the lines of weakness, and the width of the connecting part is less than the width of an accommodation unit.
- the connecting parts are then narrower than the accommodation units.
- each accommodation unit substantially corresponds to the circumference of the object accommodated in it. If the blister pack according to the invention is filled with, for example, disc-shaped pills, which are substantially round, it is preferable for each accommodation unit also to be of a round shape.
- the blister pack can comprise various materials.
- the base sheet of the accommodation units is made of aluminium
- the cap part of the accommodation units is made of plastic, such as polyvinyl chloride (PVC) or polyethylene terephthalate (PET).
- PVC polyvinyl chloride
- PET polyethylene terephthalate
- the base sheet and/or the cap part can, however, also comprise other materials.
- amorphous polyamide PA
- polyethylene naphthalate PEN
- PCTFE polychlorotrifluoroethylene
- PVC polyvinyl chloride
- PVDC polyvinylidene chloride
- PP polypropylene
- COC cyclo-olefin copolymer
- LCP liquid crystal polymer
- EVOH ethylene vinyl alcohol
- PVOH polyvinyl alcohol
- PAN polyacrylonitrile
- PS polystyrene
- biaxially oriented polyamide OPA
- chlorotrifluoroethyelene CTFE
- HDPE high-density polyethylene
- LDPE low- density polyethylene
- the base sheet and/or the cap part can also be made of, for example, any combination of the abovementioned materials.
- the invention also relates to an assembly of a blister pack of the type described above and a container in which said blister pack is accommodated. It is possible here for the blister pack to be folded up in zigzag fashion and for the dimensions of the container to correspond substantially to the dimensions of the folded blister pack. The blister pack folded up in zigzag fashion is then accommodated in a close fit in the container, for example a box. The pack formed by the assembly is compact.
- the invention furthermore relates to a method for packaging objects such as tablets, pills or capsules, comprising the provision of a blister pack of the type described above and folding up the blister pack, preferably in zigzag fashion, along the lines of weakness.
- Figures IA-D show four side views of a blister pack according to a first embodiment, folded up substantially in zigzag fashion, the opening out of two accommodation units being shown in four steps;
- Figures 2A-D show four top views of the embodiment shown in Figures IA-D;
- Figures 3A-D show four top views of a blister pack according to a second embodiment, folded up substantially in zigzag fashion, the opening out of two pairs of accommodation units being shown in four steps;
- Figure 4 A shows an elevational view in cross section of an accommodation unit of the embodiments shown in Figures 1 and 2;
- Figures 4B-C show a top view and side view of the accommodation unit shown in Figure 4A;
- Figure 5 shows a side view of a blister pack in a folded state
- Figure 6 shows a side view of the blister pack shown in Figure 5 in a semi-folded state
- Figure 7 shows a side view of the blister pack shown in Figure 5 in a substantially fully opened-out state
- Figures 8A-D show four top views of four different embodiments of connecting parts of a blister pack respectively;
- Figure 9 shows an enlarged top view of an accommodation unit and a connecting part
- Figure 10 shows two side views of a blister pack, in which the length of the connecting part is twice the height of the accommodation unit;
- Figures 1 IA, B are views of a blister pack which can be rolled up around a core body
- Figure 12 shows a side view of a further embodiment of a blister pack in a folded state
- Figure 13 shows a side view of the embodiment shown in Figure 12, in an opened-out state.
- the embodiment of the blister pack shown in Figures 1 and 2 comprises a strip of ten accommodation units 1.
- the number of accommodation units can, of course, be different.
- the accommodation units 1 form a single row.
- the blister pack has several pairs of accommodation units directly connected to each other.
- a line of weakness 2 is situated between each pair of accommodation units 1.
- the blister pack comprises a number of connecting parts 3— in this exemplary embodiment four connecting parts 3.
- the connecting parts 3 are provided between two pairs of accommodation units 1 in each case.
- the connecting parts 3 are connected by means of lines of weakness 2 to the adjacent accommodation units 1.
- the blister pack can be folded up in zigzag fashion along the lines of weakness to the state shown in Figure IA. From the folded state the accommodation units can be opened out or deployed, as shown in Figures IB-D.
- Figures IA and IB furthermore show diagrammatically by dashed and dotted lines a container in which the blister pack can be accommodated.
- the blister pack forms a primary pack
- the container forms a secondary pack.
- the dimensions of the container are adapted to the dimensions of the blister pack in the folded state. Between the inside of the container and the folded blister pack there is only a relatively small amount of play.
- the container can be in different forms.
- the container is in the form of a cardboard box with a lip on one end face or on both end faces. The lip can be opened out to reach the blister pack.
- the blister pack according to the invention can be adapted to this. This means that no accommodation units remain unused, as regularly occurs in the case of known pharmaceutical blister packs.
- the embodiment shown in Figure 3 comprises two parallel strips of accommodation units 1.
- the strips form two adjacent rows of accommodation units 1.
- the accommodation units 1 of each strip are connected to each other in pairs by one connecting part 3 in each case.
- Each connecting part 3 is connected by way of two opposite lines of weakness 2 to two accommodation units 1 in each case, which accommodation units are directly connected to each other by way of a line of weakness
- accommodation units 1 are fixed to each other at laterally adjacent accommodation units 1 thereof in each case.
- this exemplary embodiment comprises two strips of ten accommodation units 1, i.e. a total of twenty accommodation units 1, said double blister pack can, of course, comprise more or fewer accommodation units 1.
- the accommodation units 1 of the embodiments shown in Figures 1 and 2 each comprise a piercable base sheet or bottom sheet 5 and a cap part 4, which is fixed to the base sheet 5 (see Figure 4A).
- the cap part 4 of each accommodation unit 1 has a circumferential edge which is aligned relative to the piercable base sheet 5 (see also Figures 4B and 4C).
- the cap part 4 and the base sheet 5 bound an interior accommodation space 7.
- the accommodation space 7 contains a dosage form 6 of a pharmaceutical formulation which is suitable for enteral or oral administration, such as tablets, pills or capsules.
- the dosage forms 6 form objects packed in the blister pack.
- Figure 4A shows furthermore that the connecting part 3 can have a further line of weakness 2 ⁇
- the line of weakness 2' is, for example, provided centrally between the lines of weakness 2 by means of which the connecting part 3 is connected to the adjacent accommodation units 1.
- the further line of weakness 2' reduces the risk of the base sheet 5 tearing when an accommodation unit 1 is removed from the blister pack.
- Said blister pack can comprise one strip or two or more laterally connected strips of accommodation units 1.
- the strip or strips in Figures 5 - 7 comprise six accommodation units, the number of accommodation units 1 can differ from this number.
- the accommodation units 1 are connected to each other in pairs in each case by a connecting part 3, which is provided with lines of weakness 2.
- Each accommodation unit 1 is connected on either side of said unit by way of a line of weakness 2 in each case to a connecting part 3 and a further accommodation unit 1 respectively.
- the connecting part 3 can be designed in various ways according to the invention.
- the connecting part is formed as shown in Figures 8A-D.
- the connecting parts 3, 103, 203, 303 are provided between two pairs of accommodation units 1.
- the connecting parts 3, 103, 203, 303 are connected by way of lines of weakness 2 to said pairs of accommodation units 1.
- the accommodation units 1 according to the invention can be of a round shape.
- the line of weakness between the accommodation unit 1 and the connecting part 3 is preferably straight, but it can also correspond to the round shape of the accommodation unit (see Figure 9).
- the cap part 4 is connected to the piercable base sheet 5 for the purpose of protecting the enclosed object 6. There may be play between the object 6 and the cap part 4 and/or base sheet 5.
- the length L of the connecting part 3 is twice the height H of the accommodation units 1.
- the accommodation units 1 are connected to each other in pairs by way of the lines of weakness 2, with the interposition of a connecting element 3 in each case.
- the accommodation units 1 of each pair are likewise connected to each other by way of a line of weakness 2. Adapting the length L of the connecting parts 3 and the height H of the accommodation units 1 of the blister pack to each other makes the blister pack particularly compact in the folded state.
- the strip of accommodation units 1 and connecting parts 3 which are connected by lines of weakness 2 is rolled up in a direction 9 around a core body 8.
- one strip or a plurality of strips of accommodation units 1 laterally connected to each other can be rolled up on the core body 8.
- said rolled-up strip or strips of accommodation units not to have any connecting parts 3, i.e. the accommodation units in this case are connected to each other only by way of lines of weakness.
- FIGs 12 and 13 Said blister pack can be folded up in zigzag fashion along the lines of weakness 2, the base sheets 5 resting against the cap parts 4.
- the blister pack is shown opened out in Figure 13.
- a connecting part 3 is situated between each pair of adjacent accommodation units 1, which connecting part is connected by way of lines of weakness 2 to said accommodation units 1.
- the cap parts 4 of adjacent accommodation units 1 lie on either side of the base sheet 5.
- the length of the connecting parts 3 in this exemplary embodiment is substantially equal to the height of the accommodation units 1.
- the invention is not limited by the exemplary embodiments shown in the figures, which the person skilled in the art can adapt in various ways.
- the number of accommodation units 1 of the blister pack according to the invention can be extended by adding further strips of accommodation units 1 and connecting parts 3 and/or extending one or more strips by adding further accommodation units 1 and connecting parts 3. It is also possible according to the invention for more than one or two accommodation units 1 to be provided between two connecting parts 3 of a strip. It is even possible for the number of accommodation units 1 between two connecting parts 3 in a strip of accommodation units 1 and connecting parts 1 to vary.
Landscapes
- Engineering & Computer Science (AREA)
- Mechanical Engineering (AREA)
- Chemical & Material Sciences (AREA)
- Composite Materials (AREA)
- Packages (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NL1030608A NL1030608C2 (en) | 2005-12-06 | 2005-12-06 | Blister package, assembly of a blister package and a holder, and method for packaging objects. |
PCT/NL2006/050306 WO2007067054A1 (en) | 2005-12-06 | 2006-12-06 | Blister pack with fold lines |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1957378A1 true EP1957378A1 (en) | 2008-08-20 |
EP1957378B1 EP1957378B1 (en) | 2012-08-22 |
Family
ID=37757090
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP06824308A Not-in-force EP1957378B1 (en) | 2005-12-06 | 2006-12-06 | Blister pack with fold lines |
Country Status (5)
Country | Link |
---|---|
US (1) | US20080302695A1 (en) |
EP (1) | EP1957378B1 (en) |
HK (1) | HK1120481A1 (en) |
NL (1) | NL1030608C2 (en) |
WO (1) | WO2007067054A1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8261909B2 (en) | 2009-09-18 | 2012-09-11 | Colgate-Palmolive Company | Display package for a plurality of products |
CN111263727A (en) * | 2017-10-26 | 2020-06-09 | 荷兰联合利华有限公司 | Product package |
CN111278744A (en) * | 2017-10-26 | 2020-06-12 | 荷兰联合利华有限公司 | Product package |
Families Citing this family (61)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9198608B2 (en) | 2005-04-28 | 2015-12-01 | Proteus Digital Health, Inc. | Communication system incorporated in a container |
US8912908B2 (en) | 2005-04-28 | 2014-12-16 | Proteus Digital Health, Inc. | Communication system with remote activation |
US8802183B2 (en) | 2005-04-28 | 2014-08-12 | Proteus Digital Health, Inc. | Communication system with enhanced partial power source and method of manufacturing same |
CN103259027A (en) | 2005-04-28 | 2013-08-21 | 普罗透斯数字保健公司 | Pharma-informatics system |
US8836513B2 (en) | 2006-04-28 | 2014-09-16 | Proteus Digital Health, Inc. | Communication system incorporated in an ingestible product |
US8547248B2 (en) | 2005-09-01 | 2013-10-01 | Proteus Digital Health, Inc. | Implantable zero-wire communications system |
EP2013829A4 (en) | 2006-05-02 | 2010-07-07 | Proteus Biomedical Inc | Patient customized therapeutic regimens |
KR101611240B1 (en) | 2006-10-25 | 2016-04-11 | 프로테우스 디지털 헬스, 인코포레이티드 | Controlled activation ingestible identifier |
US8718193B2 (en) | 2006-11-20 | 2014-05-06 | Proteus Digital Health, Inc. | Active signal processing personal health signal receivers |
WO2008095183A2 (en) | 2007-02-01 | 2008-08-07 | Proteus Biomedical, Inc. | Ingestible event marker systems |
US8956288B2 (en) | 2007-02-14 | 2015-02-17 | Proteus Digital Health, Inc. | In-body power source having high surface area electrode |
EP2063771A1 (en) | 2007-03-09 | 2009-06-03 | Proteus Biomedical, Inc. | In-body device having a deployable antenna |
US8932221B2 (en) | 2007-03-09 | 2015-01-13 | Proteus Digital Health, Inc. | In-body device having a multi-directional transmitter |
ITBO20070186A1 (en) * | 2007-03-16 | 2008-09-17 | Mechatronic Engineering S R L | PACKAGE FOR CONFETTI, CANDIES AND THE LIKE |
US8115618B2 (en) | 2007-05-24 | 2012-02-14 | Proteus Biomedical, Inc. | RFID antenna for in-body device |
PT2192946T (en) | 2007-09-25 | 2022-11-17 | Otsuka Pharma Co Ltd | In-body device with virtual dipole signal amplification |
WO2009070773A1 (en) | 2007-11-27 | 2009-06-04 | Proteus Biomedical, Inc. | Transbody communication systems employing communication channels |
WO2009105858A1 (en) * | 2008-02-28 | 2009-09-03 | Winpak Heat Seal Packaging Inc. | Extrusion-coated lidding foil for push-through blister packaging |
ES2636844T3 (en) | 2008-03-05 | 2017-10-09 | Proteus Biomedical, Inc. | Ingestible multimode communication systems and markers, and methods to use them |
USD594348S1 (en) | 2008-06-24 | 2009-06-16 | Colgate-Palmolive Company | Multiple product package |
EP3427660A1 (en) | 2008-07-08 | 2019-01-16 | Proteus Digital Health, Inc. | Ingestible event marker data framework |
US20110121019A1 (en) * | 2008-07-10 | 2011-05-26 | 2P2D Solutions Ltd. | Device for Drug Distribution and Method of Using Thereof |
WO2010019778A2 (en) | 2008-08-13 | 2010-02-18 | Proteus Biomedical, Inc. | Ingestible circuitry |
CN102341031A (en) | 2009-01-06 | 2012-02-01 | 普罗秋斯生物医学公司 | Ingestion-related biofeedback and personalized medical therapy method and system |
KR20110104079A (en) | 2009-01-06 | 2011-09-21 | 프로테우스 바이오메디컬, 인코포레이티드 | Pharmaceutical dosages delivery system |
CA2750734C (en) | 2009-03-16 | 2013-11-05 | Colgate-Palmolive Company | Display package |
US8540664B2 (en) | 2009-03-25 | 2013-09-24 | Proteus Digital Health, Inc. | Probablistic pharmacokinetic and pharmacodynamic modeling |
NZ619375A (en) | 2009-04-28 | 2015-03-27 | Proteus Digital Health Inc | Highly reliable ingestible event markers and methods for using the same |
US9149423B2 (en) | 2009-05-12 | 2015-10-06 | Proteus Digital Health, Inc. | Ingestible event markers comprising an ingestible component |
EP2467707A4 (en) | 2009-08-21 | 2014-12-17 | Proteus Digital Health Inc | Apparatus and method for measuring biochemical parameters |
TWI517050B (en) | 2009-11-04 | 2016-01-11 | 普羅托斯數位健康公司 | System for supply chain management |
UA109424C2 (en) | 2009-12-02 | 2015-08-25 | PHARMACEUTICAL PRODUCT, PHARMACEUTICAL TABLE WITH ELECTRONIC MARKER AND METHOD OF MANUFACTURING PHARMACEUTICAL TABLETS | |
US8479921B2 (en) | 2009-12-09 | 2013-07-09 | Amcor Flexibles, Inc. | Child resistant blister package |
PL2353573T3 (en) * | 2010-02-10 | 2013-01-31 | E Pharma Trento S P A | New strengthened blister pack |
EP2547307B1 (en) * | 2010-03-18 | 2014-09-03 | MedComb Holding ApS | A system for opening a medical blister package |
WO2011127252A2 (en) | 2010-04-07 | 2011-10-13 | Proteus Biomedical, Inc. | Miniature ingestible device |
TWI557672B (en) | 2010-05-19 | 2016-11-11 | 波提亞斯數位康健公司 | Computer system and computer-implemented method to track medication from manufacturer to a patient, apparatus and method for confirming delivery of medication to a patient, patient interface device |
EP2642983A4 (en) | 2010-11-22 | 2014-03-12 | Proteus Digital Health Inc | Ingestible device with pharmaceutical product |
US20120145585A1 (en) | 2010-12-08 | 2012-06-14 | Id-Con, Llc | Packaging systems and methods |
EP2670398B1 (en) * | 2011-02-04 | 2017-06-07 | TARIS Biomedical LLC | Implantable device for controlled release of low solubility drug |
WO2015112603A1 (en) | 2014-01-21 | 2015-07-30 | Proteus Digital Health, Inc. | Masticable ingestible product and communication system therefor |
US9756874B2 (en) | 2011-07-11 | 2017-09-12 | Proteus Digital Health, Inc. | Masticable ingestible product and communication system therefor |
WO2013013108A2 (en) | 2011-07-19 | 2013-01-24 | Id-Con, Llc | Packaging systems and methods |
MX340001B (en) | 2011-07-21 | 2016-06-20 | Proteus Digital Health Inc | Mobile communication device, system, and method. |
US9235683B2 (en) | 2011-11-09 | 2016-01-12 | Proteus Digital Health, Inc. | Apparatus, system, and method for managing adherence to a regimen |
WO2013128459A1 (en) * | 2012-03-01 | 2013-09-06 | 2P2D Solutions Ltd. | Folded blister chain, folding machine and folding method |
JP2015534539A (en) | 2012-07-23 | 2015-12-03 | プロテウス デジタル ヘルス, インコーポレイテッド | Technique for producing an ingestible event marker with an ingestible component |
JP5869736B2 (en) | 2012-10-18 | 2016-02-24 | プロテウス デジタル ヘルス, インコーポレイテッド | Apparatus, system, and method for adaptively optimizing power dissipation and broadcast power in a power supply for a communication device |
US11149123B2 (en) | 2013-01-29 | 2021-10-19 | Otsuka Pharmaceutical Co., Ltd. | Highly-swellable polymeric films and compositions comprising the same |
US11744481B2 (en) | 2013-03-15 | 2023-09-05 | Otsuka Pharmaceutical Co., Ltd. | System, apparatus and methods for data collection and assessing outcomes |
WO2014144738A1 (en) | 2013-03-15 | 2014-09-18 | Proteus Digital Health, Inc. | Metal detector apparatus, system, and method |
US9796576B2 (en) | 2013-08-30 | 2017-10-24 | Proteus Digital Health, Inc. | Container with electronically controlled interlock |
US10084880B2 (en) | 2013-11-04 | 2018-09-25 | Proteus Digital Health, Inc. | Social media networking based on physiologic information |
KR101483482B1 (en) * | 2013-12-10 | 2015-01-29 | 주식회사 블리스팩 | Blister package improved product image conveying |
AU2016209379A1 (en) | 2015-01-21 | 2017-08-31 | Mylan Inc. | Medication packaging and dose regimen system |
US11051543B2 (en) | 2015-07-21 | 2021-07-06 | Otsuka Pharmaceutical Co. Ltd. | Alginate on adhesive bilayer laminate film |
US10187121B2 (en) | 2016-07-22 | 2019-01-22 | Proteus Digital Health, Inc. | Electromagnetic sensing and detection of ingestible event markers |
TWI735689B (en) | 2016-10-26 | 2021-08-11 | 日商大塚製藥股份有限公司 | Methods for manufacturing capsules with ingestible event markers |
WO2019081528A1 (en) * | 2017-10-26 | 2019-05-02 | Unilever Plc | Product packaging |
CN109573324A (en) * | 2019-01-16 | 2019-04-05 | 叶卫东 | Disposable replenisher Packaging Bottle |
CN112849492A (en) * | 2021-01-14 | 2021-05-28 | 王骏桃 | Packaging method of novel solid beverage with flaky filter bag |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2771214A (en) * | 1953-09-14 | 1956-11-20 | Ivers Lee Co | Dispensing carton for package strips |
FR1127554A (en) * | 1955-06-04 | 1956-12-19 | Showcase in relief | |
US3659706A (en) | 1970-04-24 | 1972-05-02 | Parke Davis & Co | Pharmacal package construction |
DE2322055A1 (en) * | 1973-05-02 | 1975-01-30 | Bosch Gmbh Robert | CHILD RESISTANT TABLET PACK |
GB2096574B (en) | 1981-04-10 | 1985-07-10 | Fraser Chemicals Nottingham Lt | Package assemblies |
US5046618A (en) * | 1990-11-19 | 1991-09-10 | R. P. Scherer Corporation | Child-resistant blister pack |
SE9502370D0 (en) * | 1995-06-30 | 1995-06-30 | Astra Ab | Blister pack, especially for drugs, as well as method and device in manufacturing the same |
SE515129C2 (en) * | 1996-07-01 | 2001-06-11 | Astrazeneca Ab | Blister pack, apparatus and method for manufacturing a blister pack and use of a blister pack |
US5957358A (en) * | 1997-11-14 | 1999-09-28 | Eveready Battery Company, Inc. | Battery strip dispenser |
CN1286809A (en) * | 1998-11-18 | 2001-03-07 | 永备电池有限公司 | Battery strip dispenser |
US6273260B1 (en) * | 2000-03-08 | 2001-08-14 | Eli Lilly And Company | Pharmaceutical packaging system |
US6845883B2 (en) * | 2001-10-18 | 2005-01-25 | Kenneth H. Pieri | Toothpaste dispenser |
-
2005
- 2005-12-06 NL NL1030608A patent/NL1030608C2/en not_active IP Right Cessation
-
2006
- 2006-12-06 WO PCT/NL2006/050306 patent/WO2007067054A1/en active Application Filing
- 2006-12-06 EP EP06824308A patent/EP1957378B1/en not_active Not-in-force
- 2006-12-06 US US12/096,400 patent/US20080302695A1/en not_active Abandoned
-
2009
- 2009-02-11 HK HK09101256.8A patent/HK1120481A1/en not_active IP Right Cessation
Non-Patent Citations (1)
Title |
---|
See references of WO2007067054A1 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8261909B2 (en) | 2009-09-18 | 2012-09-11 | Colgate-Palmolive Company | Display package for a plurality of products |
US8511467B2 (en) | 2009-09-18 | 2013-08-20 | Colgate-Palmolive Company | Display package for a plurality of products |
CN111263727A (en) * | 2017-10-26 | 2020-06-09 | 荷兰联合利华有限公司 | Product package |
CN111278744A (en) * | 2017-10-26 | 2020-06-12 | 荷兰联合利华有限公司 | Product package |
US11708203B2 (en) | 2017-10-26 | 2023-07-25 | Conopco, Inc. | Product packaging |
Also Published As
Publication number | Publication date |
---|---|
US20080302695A1 (en) | 2008-12-11 |
WO2007067054A1 (en) | 2007-06-14 |
NL1030608C2 (en) | 2007-06-07 |
HK1120481A1 (en) | 2009-04-03 |
EP1957378B1 (en) | 2012-08-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1957378B1 (en) | Blister pack with fold lines | |
US6253920B1 (en) | Blister pack | |
US7631764B2 (en) | Package for a personal care product | |
KR100408580B1 (en) | Spiral packaging containers for contact lenses and composite packaging materials to accommodate them | |
JP4446745B2 (en) | Drug treatment blister card | |
US20030006163A1 (en) | Childproof blister packaging | |
CA2491007A1 (en) | Package for dispensing individual portions | |
JP2004502611A (en) | Unit dose blister packaging with keyhole shaped openings | |
EP2353573B1 (en) | New strengthened blister pack | |
MX2011002370A (en) | Childproof individual dose packaging for transdermal therapeutic systems or film-like forms of administration. | |
NO338848B1 (en) | film container | |
CN103189280A (en) | Childresistant box for objects and a blank | |
CN112074468A (en) | Sanitary tissue paper package | |
USRE37558E1 (en) | Packaging arrangement for contact lenses | |
US20110233267A1 (en) | Pack having tear-open aid | |
RU2802709C2 (en) | Child-proof packaging | |
JP3215140U (en) | Paper diaper delivery box | |
JP2002531333A (en) | Packaging means for drugs in the form of a folding box combination for at least two different primary packs | |
US11866240B2 (en) | Child-resistant packaging | |
CN217375628U (en) | Plastic-aluminum bubble plate packing box | |
CA2197786C (en) | Blister pack | |
OA20511A (en) | Child-resistant packaging | |
GB2400600A (en) | Separator for a sandwich pack |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20080605 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1120481 Country of ref document: HK |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
DAX | Request for extension of the european patent (deleted) | ||
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 571845 Country of ref document: AT Kind code of ref document: T Effective date: 20120915 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602006031622 Country of ref document: DE Effective date: 20121018 |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: T3 |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1120481 Country of ref document: HK |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 571845 Country of ref document: AT Kind code of ref document: T Effective date: 20120822 |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D Effective date: 20120822 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120822 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120822 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120822 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20121222 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120822 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20121123 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120822 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20121224 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120822 Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120822 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120822 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120822 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20121203 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120822 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120822 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120822 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120822 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed |
Effective date: 20130523 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20121122 Ref country code: MC Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20121231 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602006031622 Country of ref document: DE Effective date: 20130523 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120822 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20121206 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20061206 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 10 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 11 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 12 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NL Payment date: 20171213 Year of fee payment: 12 Ref country code: FR Payment date: 20171229 Year of fee payment: 12 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IE Payment date: 20171229 Year of fee payment: 12 Ref country code: CH Payment date: 20171221 Year of fee payment: 12 Ref country code: GB Payment date: 20171228 Year of fee payment: 12 Ref country code: BE Payment date: 20171221 Year of fee payment: 12 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20180228 Year of fee payment: 12 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20171222 Year of fee payment: 12 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R119 Ref document number: 602006031622 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MM Effective date: 20190101 |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20181206 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190101 |
|
REG | Reference to a national code |
Ref country code: BE Ref legal event code: MM Effective date: 20181231 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190702 Ref country code: IT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20181206 Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20181206 Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20181231 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20181231 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20181231 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20181231 Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20181206 |